LADENBURG THALMANN FINANCIAL SERVICES INC. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 20 filers reported holding SEELOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,000
+50.0%
2,015
-4.6%
0.00%
Q3 2019$2,000
-60.0%
2,1130.0%0.00%
Q2 2019$5,0002,113
+1786.6%
0.00%
Q1 2019$01120.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders